Literature DB >> 28717005

Lipid oxidation inactivates the anticoagulant function of protein Z-dependent protease inhibitor (ZPI).

Xin Huang1, Baoxin Liu2, Yidong Wei3, Ryan Beyea4, Han Yan5, Steven T Olson6.   

Abstract

Lipid oxidation due to oxidative stress plays an important role in the pathogenesis of inflammatory and thrombotic cardiovascular diseases. Several findings suggest that lipid peroxidation can alter the function of coagulation proteins and contribute to a hypercoagulable state, but the molecular mechanisms are unclear. Here, we report that oxidized phospholipids suppress the anticoagulant function of the serpin, protein Z-dependent protease inhibitor (ZPI), a specific inhibitor of membrane-associated factor Xa (FXa) that requires protein Z (PZ), phospholipid, and calcium as cofactors. We found that this suppression arises from a diminished ability of the oxidized membrane to function as a cofactor to promote ZPI inhibition of membrane-bound FXa, due fully or in part to the susceptibility of the bound ZPI-PZ complex to oxidative inactivation. Surprisingly, free ZPI was also susceptible to inactivation by oxidized membrane vesicles in the absence of calcium. Oxidized vesicles containing both phosphatidylserine and polyunsaturated fatty acids were required to promote inactivation of the ZPI-PZ complex or free ZPI, indicating that binding of the PZ-complexed or free ZPI to peroxide-modified phospholipid vesicles mediates the inactivation. Heparin protected the ZPI-PZ complex and free ZPI from inactivation, suggesting that blocking the heparin-binding site on ZPI interferes with ZPI binding to lipid or to PZ. This was confirmed by direct lipid-binding experiments. Native PAGE indicated that oxidization induced dissociation of the ZPI-PZ complex and increased the negative charge of ZPI. We conclude that compromised ZPI anticoagulant function could contribute to thrombus initiation and growth in oxidative stress-induced cardiovascular diseases.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  coagulation factor; lipid oxidation; protease inhibitor; serpin; thrombosis

Mesh:

Substances:

Year:  2017        PMID: 28717005      PMCID: PMC5582853          DOI: 10.1074/jbc.M117.793901

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  Protein oxidation in aging, disease, and oxidative stress.

Authors:  B S Berlett; E R Stadtman
Journal:  J Biol Chem       Date:  1997-08-15       Impact factor: 5.157

2.  Prothrombinase acceleration by oxidatively damaged phospholipids.

Authors:  E A Weinstein; H Li; J A Lawson; J Rokach; G A FitzGerald; P H Axelsen
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

3.  Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin.

Authors:  S T Olson; I Björk; J D Shore
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

4.  Lipid oxidation enhances the function of activated protein C.

Authors:  O Safa; K Hensley; M D Smirnov; C T Esmon; N L Esmon
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

5.  Basis for the specificity and activation of the serpin protein Z-dependent proteinase inhibitor (ZPI) as an inhibitor of membrane-associated factor Xa.

Authors:  Xin Huang; Alexey Dementiev; Steven T Olson; Peter G W Gettins
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

6.  Characterization of the protein Z-dependent protease inhibitor.

Authors:  X Han; R Fiehler; G J Broze
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

7.  Characterization of the heparin-binding site of the protein z-dependent protease inhibitor.

Authors:  Likui Yang; Qiulan Ding; Xin Huang; Steven T Olson; Alireza R Rezaie
Journal:  Biochemistry       Date:  2012-05-02       Impact factor: 3.162

8.  Regulation of protein C inhibitor (PCI) activity by specific oxidized and negatively charged phospholipids.

Authors:  Julia M Malleier; Olga Oskolkova; Valery Bochkov; Ingrid Jerabek; Barbora Sokolikova; Thomas Perkmann; Johannes Breuss; Bernd R Binder; Margarethe Geiger
Journal:  Blood       Date:  2007-03-01       Impact factor: 22.113

9.  Isolation of a protein Z-dependent plasma protease inhibitor.

Authors:  X Han; R Fiehler; G J Broze
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

Review 10.  Oxidized phospholipids: from molecular properties to disease.

Authors:  Gilbert O Fruhwirth; Alexandra Loidl; Albin Hermetter
Journal:  Biochim Biophys Acta       Date:  2007-05-06
View more
  6 in total

1.  Synthesis of oxidized phospholipids by sn-1 acyltransferase using 2-15-HETE lysophospholipids.

Authors:  Gao-Yuan Liu; Sung Ho Moon; Christopher M Jenkins; Harold F Sims; Shaoping Guan; Richard W Gross
Journal:  J Biol Chem       Date:  2019-05-12       Impact factor: 5.157

2.  Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function.

Authors:  Xin Huang; Richard Swanson; Heather K Kroh; Paul E Bock
Journal:  J Biol Chem       Date:  2019-03-27       Impact factor: 5.157

3.  Discovery of novel plasma biomarkers for future incident venous thromboembolism by untargeted synchronous precursor selection mass spectrometry proteomics.

Authors:  S B Jensen; K Hindberg; T Solomon; E N Smith; J D Lapek; D J Gonzalez; N Latysheva; K A Frazer; S K Braekkan; J-B Hansen
Journal:  J Thromb Haemost       Date:  2018-08-06       Impact factor: 5.824

4.  Engineering a protein Z-dependent protease inhibitor (ZPI) mutant as a novel antagonist of ZPI anticoagulant function for hemophilia treatment.

Authors:  Xin Huang
Journal:  J Thromb Haemost       Date:  2019-09-05       Impact factor: 5.824

Review 5.  Reactive Oxygen Species in Venous Thrombosis.

Authors:  Clemens Gutmann; Richard Siow; Adam M Gwozdz; Prakash Saha; Alberto Smith
Journal:  Int J Mol Sci       Date:  2020-03-11       Impact factor: 5.923

6.  Heparin activation of protein Z-dependent protease inhibitor (ZPI) allosterically blocks protein Z activation through an extended heparin-binding site.

Authors:  Xin Huang; Richard Swanson; Steven T Olson
Journal:  J Biol Chem       Date:  2022-05-10       Impact factor: 5.486

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.